X4 Pharmaceuticals Inc
For the period ended Aug 8, 2024. Filed Aug 8, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 8, 2024 · Filed Aug 8, 2024
Use the contents to explore the available documents and sections.
XFOR$3.18+3.6%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Daniel Ferry
Daniel Ferry
Managing Director, LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.